Search Results

1

Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-Like Cells

by Brandner, S., Ernestus, R.-I, Feldheim, J., Feldheim, J.J, Glas, M., Hagemann, C., Kessler, A.F, Kleinschnitz, C., Lazaridis, L., Löhr, M., Monoranu, C.M, Schulz, E., Wend, D.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
2

Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells

by Beltzig, L., Christmann, M., Frauenknecht, K.B.M, Hegi, M.E, Kaina, B., Leukel, P., Schwarzenbach, C., Sommer, C., Tancredi, A.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
3

Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)

by Du, J., Li, S., Peng, C., Peng, F., Xie, X.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
4

Real-world evidence for option value in metastatic melanoma

by Garrison, L.P., Jr, Lee, W., Li, M., To, T.M, Veenstra, D.L, Wong, W.B
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
5

The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial

by Cheng, Y., Huang, N., Liu, G., Mao, J., Sun, M., Tao, Y., Wen, R., Xie, Z., Zhang, X., Zhao, G.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
6

CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future

by Lim, M., Lin, Y.-J, Mashouf, L.A
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
7

Hydrocephalus Shunting in Supratentorial Glioblastoma: Functional Outcomes and Management

by Beck, J., Cipriani, D., El Rahal, A., Fung, C., Heiland, H.D, Hohenhaus, M., Schnell, O., Shah, M.J, Straehle, J., Sveikata, L.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
8

Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells

by Ghanate, A.D, Immanuel, S.R.C, Panchagnula, V., Parmar, D.S, Raghunathan, A., Uthup, R., Yadav, R.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
9

Immune Landscape in PTEN-Related Glioma Microenvironment: A Bioinformatic Analysis

by Lucifero, A.G, Luzzi, S.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
10

Modeling glioblastoma heterogeneity as a dynamic network of cell states

by Dalmo, E., Doroszko, M., Elgendy, R., Jörnsten, R., Larsson, I., Nelander, S., Niklasson, M., Segerman, A., Westermark, B.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
11

A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines

by Berta, G., Brandt, B., Heffer, M., Németh, M., Pap, M., Rauch, T.A, Szünstein, M.
Published 2023

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher
View in Scopus

Article
12

NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation

by Fong, I.-H, Lin, C.-M, Liu, H.-W, Setiawan, S.A, Su, I.-C, Su, Y.-K, Yadav, V.K, Yeh, C.-T
Published 2023

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher
View in Scopus

Article